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Background. There is increasing recognition that high-performance athletes can develop symptomatic arterial flow
restriction in one or both (15%) legs due to kinking and/or endofibrosis of their iliac arteries.
Methods. Case report and review based on a Medline search of the literature.
Results. A 51-year-old female, 24-hour endurance runner presented with a six-month history of rapidly progressing
intermittent claudication affecting her right thigh and calf in the absence of classical risk factors for atherosclerosis. On the
basis of invasive and non-invasive investigations, a provisional diagnosis of endofibrosis was made and she was treated
successfully with angioplasty.
Conclusions. The epidemiology, optimal investigation and treatment of iliac endofibrosis in endurance athletes is poorly
described. Each individual unit’s experience is likely to be very small. A European register of such cases would increase our
understanding of the condition and improve patient outcomes.
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Introduction
There is increasing recognition that high-performance
athletes, predominantly professional cyclists, can
develop symptomatic arterial flow restriction in one
or both (15%) legs due to kinking and/or endofibrosis
of their (predominantly external) iliac arteries.1 – 7 A
51-year-old female, 24-hour endurance runner
recently presented to our unit with a six-month history
of rapidly progressing intermittent claudication affect-
ing her right thigh and calf in the absence of classical
risk factors for atherosclerosis (please see illustrative
case report below). A provisional diagnosis of endofi-
brosis was made and she was treated successfully with
angioplasty. In the course of investigating and treating
this patient, it became clear that there is a lack of
information about the aetiology, presentation, diag-
nosis, treatment and outcome of this condition. We,
therefore, conducted a Medline search 1966–2002
using the search terms ‘intermittent claudication’,
‘endofibrosis’, ‘iliac arteries’, ‘physical endurance’,
‘endurance athletes’, ‘bicycling’, ‘fibromuscular dys-
plasia’. We felt the results of that review would be of
interest to readers of the EJVES.
Epidemiology
At the present time it is impossible to estimate the true
prevalence of this condition. The literature mostly
consists single case reports or small series comprising
only a handful of patients, often gathered over many
years. The largest experience is that of Chevalier and
colleagues (Lyon, France) who have reported on over
200 patients undergoing surgery over a 10-year
period.7 In that series, 56% of patients were under 30
years of age and more than 90% were cyclists (15%
professional, 48% top amateur, 28% recreational). The
remaining patients, who were significantly older than
the cyclists, comprised tri-athletes (3%), cross-country
skiers (0.5%) or runners (4.5%). Other sportsmen such
as body-builders8 and rugby players9 may also be at
risk. There appears to be a direct relationship between
the frequency of the condition and the distance cycled
with the average being around 150,000 km10,11 and
some having covered up to 450,000 km.12
Site of Disease
The external iliac artery is most commonly affected
(c. 90%), followed by the common iliac and common
femoral arteries (c. 5–10% each). In c. 10% of
patients more than one segment is affected, there
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may be a left-sided predominance and c. 15% of
patients have bilateral symptoms, although the preva-
lence of occult contralateral asymptomatic disease (see
case report) may be much higher.
Aetiology
The aetiology remains incompletely defined but
appears to be related to one or more of the following.
Repeated stretching
The external iliac artery runs ventral to the axis of the
hip joint and is stretched upon hip flexion. This maybe
exacerbated by psoas muscle hypertrophy.7 The
aerodynamic position adopted by cyclists leads to
extreme hip flexion, which may explain the propensity
of this particular group to develop the condition.
External compression
As well as pushing down, professional cyclists also
pull up on the pedals. As a result, the hip flexors,
particularly psoas, become markedly hypertrophied,
and it has been suggested that this may compress the
iliac arteries. It has also been suggested that the
external iliac artery might become compressed as it
passes under the inguinal ligament due to hypertro-
phy of the abdominal musculature (primarily the
external oblique).
High flow
It has been suggested that the supra-physiological
blood flows generated in the iliac arteries of high-
performance athletes leads to endothelial dysfunc-
tion13 and injury that through, as yet unknown
mechanisms, leads to endofibrosis.
Kinking
It has been suggested that branches originating from
the external iliac artery and entering psoas lead to
tethering of the artery, which in turn exacerbates
kinking upon hip flexion.2 The other proposed tether
point is where the circumflex iliac, epigastric and
pudendal arteries leave the external iliac as it passes
under the inguinal ligament.14
Other mechanisms
It is possible, although at the present time unknown,
whether venous and/or neurological abnormalities
also contribute to the symptom complex reported by
affected athletes.
Pathology
As a result of the above and possibly other unknown
mechanisms, arterial flow restriction can occur due to
kinking alone, luminal narrowing alone, or both. With
regard to luminal narrowing, this appears to be due to
what has been termed ‘endofibrosis’, which is histo-
logically distinct from atherosclerosis and fibromus-
cular hyperplasia. Specifically, the lesion is
characterised by stenotic intimal thickening caused
by a moderately cellular loose connective tissue
containing variable amounts of elastin and collagen.
The cellular infiltrate can be stained with antibodies to
actin and myosin.15
In addition to intimal fibrosis, recent histological
evaluation of five stenotic external iliac vessels
resected from four competitive female cyclists demon-
strated a degree of medial and adventitial response to
such stress, prompting the authors to favour the term
‘external iliac arteriopathy’.16
Presentation
In our case, the patient had noticed a gradual and
unexplained deterioration in her performance over a
couple of years and had abandoned competitive
running. However, it was only when she developed
severe and rapidly progressive leg pain on what she
would consider minimal exercise (running a few
miles!) that she sought medical advice. It is clear
from reviewing the literature that only a minority of
affected athletes complain of typical claudication-type
symptoms. Rather, they present with an unexplained
deterioration in performance, ‘weakness’, ‘lack of
power, ‘swelling’, and a ‘feeling of paralysis’.5
Whether these atypical symptoms represent true
arterial (and venous?) (compression, kinking) or
neurological (compression, stretching, ischaemia) is
uncertain. However, as the symptoms usually vague
and non-specific, findings on physical examination at
rest often unremarkable, and the ‘super-fit’ are
considered unlikely to develop vascular disease,
there is often a long delay between symptoms first
developing and the diagnosis being made (please see
below).5,17 The average delay appears to be around
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2 years (40,000 km cycling)7 during which time the
athlete may be forced to drop out of competition,
never to return.
Diagnosis
In our case, the diagnosis was relatively straightfor-
ward as the patient presented late with symptoms
typical of claudication and a reduced femoral pulse on
the affected side on clinical examination. However,
making a diagnosis at an earlier stage where the only
‘symptom’ is a non-specific impairment in perform-
ance and clinical examination is within normal limits
may be much more problematic.
Physical examination. The great majority of affected
athletes will have normal pulses because the degree of
luminal narrowing is insufficient to cause a clinically
detectable pressure drop at rest, or because the
underlying pathology is kinking that only manifests
itself at the extremes of flexion. There may be a bruit
but usually only after exercise and/or during maxi-
mum hip flexion.7
Ankle:Brachial Pressure Index (ABPI). Similarly, the
ABPI will usually be normal at rest.10,18 Exercise may
produce a detectable fall in ABPI but on cessation of
exercise the pressure may return to normal so quickly
that it is easily missed unless the ankle pressure is
measured almost immediately. Furthermore, the nor-
mal practice of obtaining pressures with the patient
supine and the hip extended may be inappropriate in
such cases.
Exercise testing. Apart from the rapid recovery in
ABPI noted above, standard exercise testing is often
uninformative because the exercise used is simply not
extreme or prolonged enough to mimic the situation
found during competition. Furthermore, treadmill
testing may not mimic the muscle usage and extremes
of hip flexion experienced by the athlete who are most
often cyclists. Several groups have described specific
cycle-ergometer based testing protocols designed to
overcome these difficulties but clearly they are not
widely available.5,7,10
Ultrasound examination. Even in expert hands the
diagnosis can be difficult to make on ultrasound
examination because velocities and waveforms are
usually normal except at extremes of exercise and/or
hip movement during which the artery is difficult to
insonate. The only clue to the underlying pathophy-
siology may be an impression of mildly hyperechoic
segmental myointimal thickening (c. 0.3 mm) in axial
view, which is easily overlooked.10,18,19 Intra-vascular
ultrasound (IVUS) can also show the degree and
distribution of intimal thickening and may be a useful
adjunct when other investigations including angio-
graphy and measurement of pressure gradient (see
below) are uninformative.20
Intra-arterial digital subtraction angiography (IA-
DSA). Unless angiographic images are obtained in
multiple planes and in different positions of hip
flexion and extension, the subtle, irregular and
eccentric angiographic abnormalities associated with
the disease may be missed. The most characteristic
angiographic finding appears to be a beaded or
smooth stenotic appearance that most commonly
starts just distal to the common iliac bifurcation and
extends some 5–6 cm down the external iliac artery.7,10
Calcification is typically absent. In some cases,
narrowing of the arterial lumen can only be appreci-
ated by directly comparing like images of the affected
with the non-affected side. Pressure measurements are
likely to be normal at rest but a gradient may become
detectable across the affected segment after vasodila-
tor induced distal vasodilatation.10
Magnetic resonance angiography (MRA). As yet, there
is limited experience with Gadolinium enhanced MRA
in this condition but the technique may represent a
major advance7 as it is non-invasive, non-toxic,
provides a resolution similar to IA-DSA, and images
can be obtained in different hip positions and
processed to provide 3-D reconstructions. This may
aid diagnosis, provide further understanding with
respect to aetiology and by differentiating kinking
from luminal narrowing help to guide treatment. A
prospective study,12 found MRA to be more sensitive
than IA-DSA.
Treatment
Once the diagnosis has been made, there is little
consensus on optimal treatment and almost no data on
the long-term outcomes.
Best medical therapy (BMT). Although it intuitively
makes sense to institute ‘best medical therapy’
(comprising smoking cessation, anti-platelet agents,
statin therapy etc.), it must be remembered that
‘endofibrosis’ is distinct from atherosclerosis and the
prevalence of conventional vascular risk factors is
likely to be very low in this population. One report
suggested a high prevalence of hyperhomocysteinae-
mia in affected individuals but the significance of this
is, as yet, unknown.7 It has been suggested that the
condition may improve over time with conservative
therapy, and certainly progression to disabling clau-
dication on walking or critical limb ischaemia seems
very unlikely. In some cases it may be possible to
modify the athletes level and type of activity to
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ameliorate the symptoms. For example, cyclists can be
advised to alter their riding position to reduce hip
flexion and not to pull actively on the pedal. However,
in many cases, without intervention the condition
effectively spells the end of the athlete’s competitive
career. Most authorities seem agreed that intervention
should not be undertaken lightly and is only indicated
once it is clear that all non-interventional options have
been exhausted. The balance of risks and benefits is
clearly going to be quite different for the recreational
athlete and the Olympian.
Endovascular therapy. Minimally invasive therapy
has obvious attractions and previous authors have
reported successful return to competition following
percutaneous transluminal balloon angioplasty
(PTBA).10 However, several authors have counselled
against the use the use of PTBA for fear risk of
initiating a dissection due to the loose attachment
between the intimal endofibrotic lesion and the media
at the internal elastic lamina.21,22 Concerns have also
been expressed about the durability of angioplasty.
There is a perception that histological nature of the
lesion makes early elastic recoil and symptomatic
recurrence likely,10 although in the case described here
the patient remains symptomatically better 12 months
after an uncomplicated angioplasty. Furthermore,
symptomatic and haemodynamic improvement has
been reported despite little increase in luminal
diameter on the immediate post-angioplasty image.10
Repeated angioplasty is a theoretical option for
symptomatic recurrence but there are no reports in
the literature on which to base current practice. There
are no reports of stenting in the literature but on first
principles it would seem unwise for fear of mechanical
compression and/or disintegration, and aggressive
neo-intimal hyperplasia at the stent margins, due to
the excessive movement.
Surgery. There is a natural reluctance to subject
these athletes to surgery because of the recuperation
period, the risk of complications and concern about
subjecting vascular anastomoses to such extreme
repetitive strain. Several different procedures, either
singly or in combination, have been advocated. In this
respect, the crucial determinant seems to be dis-
tinguishing those patients in whom kinking is the
underlying problem from those in whom there is
either or also a haemodynamically significant luminal
narrowing. There are several procedures described in
the literature.
1. Arterial release. This involves dividing arterial
branches, fascia and scar tissue tethering the iliac
arteries to the psoas muscle and possibly at the
inguinal ligament. This is only indicated when the
underlying problem is kinking and luminal nar-
rowing has been confidently excluded.7 As the
integrity of the artery is not breached the risks are
likely to be minimal Shep and colleagues12 have
described their operative technique and results in a
prospective study of 23 patients (mean [range] age
30 [22–48] years, 21 men, 21 left leg). There were no
complications and the mean hospital stay was only
3 days. Post-operatively, the patients underwent
specific physiotherapy and a controlled re-intro-
duction to their sport to reduce the risks of
refibrosis. At a median (range) follow-up of six
(4–36) months, all the patients improved subjec-
tively, 12 were rendered asymptomatic and there
was a significant improvement in ABPI and peak
systolic velocities on Doppler examination.
2. Shortening of the artery. This is only appropriate if
the underlying problem is kinking and there is clear
arterial redundancy. This procedure obviously
entails breaching the integrity of the artery. The
length of artery that should be resected remains
purely empirical and a matter of judgment on a
case-by-case basis.
3. Resection of the fibrotic segment followed by
saphenous vein interposition graft. This is indi-
cated where there is narrowing but no arterial
redundancy. As the saphenous vein is usually of
lesser calibre than the artery to be replaced, and it is
important not to replace one form of functional
obstruction with another, panel and spiral grafts
appear to be frequently required and advocated.
There is general agreement that prosthetic graft
materials should be avoided.
4. Endarterectomy and vein patch angioplasty.
Illustrative Case Report
To our knowledge this is the first report associated
with endurance running. The aim of this sport is to
determine who can cover the furthest distance in 24 h;
distances exceeding 100 km are apparently not
uncommon. This case exemplifies many of the
difficulties associated with this uncommon condition.
A 51-year-old female, 24-hour endurance runner
presented with a six-month history of rapidly progres-
sing intermittent claudication affecting her right thigh
and calf. As a result, her weekly training distance had
reduced from over one hundred to only a few miles
and she had abandoned competitive running. She was
an ex-smoker of 20 years but has never smoked
heavily. There were no other major vascular risk
factors for arterial disease and no family history of
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arterial disease. Her cholesterol level was 5.0 mmol/L
and triglycerides 0.8 mmols/L.
On physical examination, the left leg appeared
normal but on the right the femoral and distal pulses
were reduced. The resting ABPI was 0.89 on the left
and 0.63 on the right.
Intra-arterial digital subtraction angiography
(IA-DSA) of the right leg demonstrated an isolated
short 5 cm proximal external iliac artery occlusion
compatible with endofibrosis (Figs. 1 and 2). The
remaining vessels were normal bilaterally.
The lesion was successfully treated with PTBA
(Fig. 2). One year following the procedure the patient
remains symptoms free with a normal right femoral
pulse and has returned to competitive running.
Although our patient appears to have had a good
outcome, at least in the short term, the case does
highlight a number of issues with regard to the
investigation and treatment of this unusual condition
and several questions remains unanswered.
Was the diagnosis truly ‘endofibrosis’? The only
vascular risk factor was very light smoking in early
adulthood but without resecting the artery it is
impossible to know whether this was endofibrosis,
or atherosclerosis, or both.
Why was the ABPI reduced on the left (the
asymptomatic side)? Angiography appeared be nor-
mal but it is possible that further images in different
planes may have revealed some disease.
How durable will the angioplasty be? And, if the
patient represents, would repeat angioplasty or
surgery or no intervention be appropriate?
Is there a role for ‘best medical therapy’ (statin,
clopidogrel, cilostazol) in such patients?23
Is there a role for thrombophilia screening including
measurement of homocysteine?24
Conclusions
This is an uncommon condition and individual
experience is likely to be small. Many questions
remain unanswered with regard to prevalence, aetiol-
ogy, diagnosis, treatment and prognosis. In common
with many rare conditions, probably the best way of
gaining and disseminating knowledge in the first
instance is through a registry of cases. Any reader
interested in developing and/or contributing to such a
registry is encouraged to contact the senior author
(andrew.bradbury@heartsol.wmids.nhs.uk). Alterna-
tively, if such a registry already exists, we would be
pleased to contribute to it.
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